shutterstock
Solcara Health Blog

Moving States on Testosterone or Estrogen: How to Keep Your Prescription Without a Gap

A pharmacy can move a testosterone refill to a pharmacy in another state once, pharmacist to pharmacist, under federal rule 21 CFR 1306.25, if the new state's pharmacy rules allow it [3]. Your prescriber is a separate question. DEA ties each prescriber's registration to a state [14]. So when you transfer a testosterone prescription to another state, plan to line up a prescriber who is licensed and registered where you will live.

A smiling man in an olive linen shirt sits on a rattan bench in a bright room on moving day, holding a kraft folder and a phone, with packed boxes beside him.

Testosterone is a Schedule III controlled substance [5]. The SC PMP report, citing DEA, describes Schedule III drugs as having a moderate to low potential for physical and psychological dependence [1]. Federal rules place "any substance meeting the definition of anabolic steroid" in Schedule III, and the list names testosterone [5]. Estrogen is not a controlled substance [6]. The federal definition of anabolic steroid excludes "estrogens, progestins, corticosteroids, and dehydroepiandrosterone" [6]. That one difference shapes the whole move.

The question is growing here. From 2020 to 2024, South Carolina's Schedule III dispensing rate rose from 134 to 142 prescriptions per 1,000 people [1]. The report says the rise appears to be driven largely by a 39% increase in testosterone cypionate prescriptions [1]. People are arriving too. South Carolina was the fastest-growing state from 2024 to 2025 [7]. The Charleston metro grew from 874,088 to 889,263 residents [2], which is 15,175 people, or about 42 a day by our arithmetic. The regional development alliance puts it at roughly 40 new residents a day since 2020 [4].

South Carolina Schedule III dispensing, 2020 to 2024
YearSchedule III prescriptions dispensed per 1,000 residentsSource
2020134[1]
2024142[1]
South Carolina Schedule III dispensing, 2020 to 2024Schedule III prescriptions per 1,000 South Carolina residents, 2020 and 2024, SC DPH, read November 9, 2026
2020134
2024142

The report says the rise appears to be driven largely by a 39% increase in testosterone cypionate prescriptions. [1]

The state report places that rise after DEA's telemedicine exceptions took effect. It does not prove the cause. [19]

Dated third-party dataset. Source: SC Department of Public Health, South Carolina Prescription Monitoring Program 2024 Annual Report. Date range: 2020 to 2024. Denominator: dispensed Schedule III prescriptions per 1,000 South Carolina residents. [1]

This guide reflects federal telehealth prescribing rules as of November 2026. This area is evolving rapidly. Check back if DEA publishes its telemedicine final rule.

Your move checklist

Shows the steps in this guide in order, with the federal rule behind each. It does not check your prescription, your state's law or your dose.

Pick your medication, then how soon you move

Testosterone

Read your label
A Schedule III prescription cannot be filled more than six months after it was issued, or refilled more than five times (21 CFR 1306.22). [8]
Book the new clinician
DEA requires a separate registration in each state where a practitioner practices (DEA registration FAQ). [14]
Ask for the pharmacy transfer
A Schedule III refill can move between pharmacies one time, pharmacist to pharmacist (21 CFR 1306.25). [3] [10]
Expect a new e-prescription
South Carolina law requires prescribers to e-prescribe controlled substances, with limited exceptions (S.C. Code Ann. 44-53-360(k)). [22]

Estrogen

Know the difference
Estrogen is not a controlled substance; federal law excludes estrogens from the anabolic steroid definition (21 U.S.C. 802). [6]
Check your new state's rules
Estrogen transfers follow state pharmacy law; check the board of pharmacy.
Book the new clinician
Your new state decides who may prescribe it.

Both

All testosterone steps, then the estrogen steps
Shows both lists; the testosterone steps carry the federal Schedule III limits. [3] [6] [8] [14]

Over 6 weeks

Start at step 1
Read your label, then book the new clinician four to six weeks out. [8] [14]

2 to 6 weeks

Start at step 2
Book the new clinician now and gather records. [14]

Under 2 weeks

Start at step 2, then step 4
Book the new clinician now and ask the new pharmacy for the one-time transfer. Do not ask for early refills or extra supply. [3] [14]

General information from federal rules and South Carolina sources read November 9, 2026. Telehealth rules as of November 2026. Your clinician, your pharmacist and your state boards decide.

Key takeaways

  • A Schedule III refill, such as testosterone, can move between pharmacies one time [3]. It is not true that a controlled prescription can never transfer [3].
  • Pharmacies that share a real-time online database may transfer up to the refills the prescriber authorized [9].
  • Estrogen is not a controlled substance [6], so the federal Schedule III limits do not apply to it. State pharmacy rules do.
  • DEA says a registration based on one state's license "cannot authorize controlled substance dispensing outside the State" [14].
  • The federal telehealth flexibilities for controlled prescriptions expire at the end of December 31, 2026 [16]. As of November 9, 2026, no later DEA telemedicine rule had been published [25].

Section 01 / Pharmacy transfers

How pharmacy transfers work for Schedule III prescriptions

A testosterone refill can move between pharmacies once. Federal rule 21 CFR 1306.25 says the transfer of Schedule III to V refill information is "permissible between pharmacies on a one-time basis only" [3]. Pharmacies that share a real-time online database may transfer up to the refills the prescriber authorized [9]. Two licensed pharmacists must handle the transfer directly [10].

That pharmacist-to-pharmacist step is the part patients do not see. The sending pharmacist voids the original prescription [10]. The pharmacist then records the receiving pharmacy's name, address and DEA number [10]. You start the process by calling the new pharmacy with your old pharmacy's details.

Two federal limits travel with a testosterone refill. A Schedule III prescription cannot be filled or refilled more than six months after the date it was issued [8]. It also cannot be refilled more than five times [8]. A transfer does not reset either limit, because the original issue date and remaining refills travel with it [8] [10].

An unfilled electronic prescription follows a different rule. Since August 28, 2023, DEA has allowed an unfilled electronic prescription for a Schedule II to V drug to move between retail pharmacies for its first fill [11]. The patient asks, and it happens once [11]. DEA's cost model used an estimated maximum of about 13.7 million of these transfers a year for each of the rule's first five years [12]. DEA also explained why you cannot carry an electronic prescription yourself. The pharmacy "cannot give the prescription to the patient to take to another pharmacy" [12].

A prescription monitoring program, or PMP, is a state database of controlled substance prescription history [21]. South Carolina's PMP is called SCRIPTS [20]. The state's 2024 report lists interstate data sharing, added in December 2020, with 44 other state PMPs, plus the District of Columbia, Puerto Rico and the Military Health System [20]. So a new South Carolina clinician can search the testosterone fills those programs hold.

RuleTestosterone (Schedule III)Estrogen (not controlled)
Federal scheduleSchedule III anabolic steroid [5]Excluded from the anabolic steroid definition [6]
Refill transfer between pharmaciesOnce, unless the pharmacies share a real-time database [3] [9]Set by state pharmacy law; check the board of pharmacy
Six-month and five-refill limitsApply [8]Not covered by the Schedule III and IV rule [6] [8]
Prescriber needs a DEA registration in the stateYes, per DEA's registration FAQ [14]No DEA registration is involved [6]

Section 02 / Your prescriber

Why your current prescriber may not be able to keep prescribing across state lines

Your current prescriber can keep prescribing testosterone after you move only if their license and DEA registration cover your new state. DEA's registration guidance says "DEA requires that the practitioner obtain a separate DEA registration in each state" where they practice [14]. It also says a registration based on one state's license cannot authorize dispensing outside that state [14].

Federal regulation ties registration to place. 21 CFR 1301.12 requires a separate registration for each principal place of business or professional practice where controlled substances are dispensed [15]. DEA reads that rule to mean a practitioner who practices in several states needs a registration in each one [14].

The state license comes first. DEA requires a practitioner to hold state authority to handle controlled substances before it will register them in that state [14]. Each state medical board sets its own licensing rules, and this guide does not summarize them. Ask your prescriber one direct question: which state license and which DEA registration will cover my new address?

Telehealth adds a second test. Under the Ryan Haight Act, a valid controlled prescription delivered by means of the Internet must come from a practitioner who has conducted "at least 1 in-person medical evaluation of the patient", or from a covering practitioner [13]. DEA explains that once a prescriber has done that one in-person evaluation, the Act's remote prescribing requirements no longer apply to that relationship [24].

Estrogen is simpler on the federal side. No DEA registration is involved, because estrogen is not a controlled substance [6]. Your new state still decides who may prescribe it and whether a pharmacy may fill an out-of-state prescription. In South Carolina, check the South Carolina Board of Medical Examiners and the South Carolina Board of Pharmacy. In another state, find its pharmacy board in the NABP directory of boards of pharmacy.

New to the Charleston area? Book a new-patient hormone visit with a Solcara clinician before your current prescription runs out, or call 843-981-0870.

Section 03 / Telehealth deadline

The December 31, 2026 telehealth deadline and what happens after it

The federal telehealth flexibilities that let a DEA-registered prescriber issue controlled prescriptions, including testosterone, without a prior in-person visit end on December 31, 2026 [16]. The rule says the authorization "expires at the end of December 31, 2026" [16]. A Federal Register search on November 9, 2026 found no later DEA telemedicine rule and no fifth extension [25].

That is the status as of November 2026. DEA and HHS set the date in a fourth temporary extension, effective January 1, 2026 [16]. The extension exists to avoid what the rule calls the "telemedicine cliff": the return of the pre-pandemic restrictions in the Controlled Substances Act [16]. The main restriction is the Ryan Haight Act rule of at least one in-person medical evaluation [13].

DEA has proposed a permanent framework, but it is only a proposal. DEA published the Special Registration for Telemedicine proposed rule on January 17, 2025 [18]. It would create three types of special registration, with heightened prescription, recordkeeping and reporting requirements [18]. As of November 9, 2026, it had not been finalized [25].

The scale is large. In the fourth extension, DEA cited one stakeholder's summary of unpublished data reviewed by Epic, Johns Hopkins and Stanford [17]. Of an estimated 44.6 million controlled substance prescriptions across 258 organizations in 2024, more than 7 million, about 16%, were issued without a prior in-person evaluation [17]. That figure is a stakeholder summary, not a DEA measurement.

South Carolina shows the same shift. From 2020 to 2024, controlled substance prescriptions dispensed in the state from out-of-state prescribers rose 13% [19]. Prescriptions from in-state prescribers rose 0.2% [19]. The state report places that rise after DEA's telemedicine exceptions took effect [19]. It does not prove the cause.

If you get testosterone from a telehealth prescriber you have never met in person, ask now what their plan is for January 1, 2027. Do not wait for December.

Section 04 / Records

Records to bring to a new hormone clinician

Bring your current prescription details, recent lab results with dates, a full medication list and your previous prescriber's contact details to a new hormone clinician. A new South Carolina prescriber can check SCRIPTS, which the state's 2024 report says shares data with 44 other state PMPs plus the District of Columbia, Puerto Rico and the Military Health System [20]. A PMP shows fills. It does not show your labs or visit notes.

Hands set a kraft folder of papers on a taped moving box, with house keys, a phone and a jar of yellow jasmine on a marble side table.
RecordWhy the new clinician needs itRule it connects to
Prescription label or printout: drug, strength, dose, issue date, refills leftShows how much time the current prescription hasSix-month and five-refill limits [8]
Current pharmacy name and phone numberLets the new pharmacy request the one-time transferPharmacist-to-pharmacist transfer [10]
Previous prescriber's name, practice and contact detailsLets the new clinician request records and confirm historyDEA registration is per state [14]
Date and place of your last in-person visitShows whether an in-person evaluation is on recordRyan Haight Act in-person evaluation [13]
Recent lab results, with datesShows your treatment history and baselinesThe new clinician decides what to repeat
Full medication list, including estrogenSeparates controlled from non-controlled drugsEstrogen is not controlled [6]
States where you filled prescriptions beforeHelps the clinician search the right PMPsSCRIPTS interstate access [20]

South Carolina law has one detail worth knowing. South Carolina law requires a prescriber to review the PMP before issuing a Schedule II prescription [21]. It exempts a supply of five days or less, among other cases [21]. Testosterone is Schedule III under federal rules [5], so that mandate does not cover it. A clinician can still check.

A new prescriber decides whether to repeat baseline labs and how soon to see you. Plan for a new-patient visit and possibly new labs. For Charleston figures, see our guides to testosterone therapy costs and advanced lab testing costs.

Section 05 / Move-week timeline

A move-week timeline that avoids a gap

To avoid a gap, book the new clinician before you move, transfer the refill once you choose the new pharmacy, and expect a fresh electronic prescription from the new prescriber. South Carolina law requires prescribers to e-prescribe controlled substances, with limited exceptions [22]. Do not ask for early refills or extra supply. The steps below work inside your normal refill schedule.

  1. Six or more weeks out: read your label. Note the issue date and refills left. A Schedule III prescription cannot be filled more than six months after it was issued, or refilled more than five times [8].
  2. Four to six weeks out: book the new clinician. Ask what records and labs they want before the first visit. Ask your current prescriber whether their license and DEA registration cover your new state [14].
  3. Two to four weeks out: gather records. Use the records table in this guide. Request lab results and visit notes in writing, with dates.
  4. Move week: choose the new pharmacy and ask for the transfer. The new pharmacist contacts the old one, and a Schedule III refill transfers one time [3] [10]. If you stay with the same chain, ask whether its stores share a real-time database [9].
  5. After the first visit: the new prescription. In South Carolina it usually reaches the pharmacy electronically [22]. If it lands at the wrong pharmacy before it is filled, you can ask for a one-time transfer for that first fill [11].
  6. Before the next refill is due: confirm the hand-off. Call the new pharmacy to confirm it has a fillable prescription on file. The old pharmacy's refills do not carry past the six-month limit [8].

Estrogen users follow the same order. The transfer rules come from your new state, not from the federal Schedule III rule, because estrogen is not a controlled substance [6].

My advice is plain. Book the prescriber before you book the movers.

Section 06 / Questions

Prescription Transfer Questions Answered

Can a testosterone prescription be transferred to another state?

Yes, one time. Federal rule 21 CFR 1306.25 lets a pharmacy transfer a Schedule III refill to another pharmacy once, pharmacist to pharmacist [3] [10]. Pharmacies that share a real-time online database can transfer up to the refills the prescriber authorized [9]. The six-month and five-refill limits still apply after the transfer [8]. Your new state's pharmacy rules apply too, so ask the new pharmacy before you move [3].

Is estrogen a controlled substance?

No. The federal definition of anabolic steroid excludes estrogens, progestins, corticosteroids and dehydroepiandrosterone [6]. Testosterone, by contrast, is Schedule III [5]. An estrogen prescription moves under your new state's pharmacy rules. Check that state's board of pharmacy.

Can my old doctor keep prescribing after I move?

Only if their license and DEA registration cover your new state [14]. DEA requires a separate registration in each state where a practitioner practices [14]. A registration based on one state's license cannot authorize dispensing outside that state, so a registration back home does not cover a prescription for you in your new state on its own [14]. DEA does let a practitioner change the address on an existing registration [23]. That rule covers the prescriber's own move, not yours.

What happens to telehealth testosterone prescribing after December 31, 2026?

The current federal flexibilities expire at the end of December 31, 2026 [16]. As of November 9, 2026, no later DEA telemedicine rule or fifth extension had been published [25]. If none follows, the Ryan Haight Act in-person evaluation rule applies again to prescribers who have not seen you in person [13] [16]. Special registration remains a proposed rule from January 2025 [18].

What records does a new hormone doctor need?

Bring your prescription details with refills left, your pharmacy's contact information, recent lab results with dates, a full medication list and your previous prescriber's contact details. Add the date of your last in-person visit. A South Carolina clinician can also check SCRIPTS, which the state's 2024 report says shares data with 44 other state PMPs [20].

Section 07 / Bottom line

Bottom line: move the prescriber, not just the prescription

A pharmacy can move your testosterone refill once [3]. That buys time. It does not replace a prescriber whose license and DEA registration cover the state where you now live [14].

So the order matters. Book the new clinician first. Bring the records. Then let the two pharmacists handle the transfer [10]. Estrogen is easier on the federal side because it is not a controlled substance [6], but your new state still sets the rules.

Watch the calendar as well. The federal telehealth flexibilities expire at the end of December 31, 2026 [16]. If your prescriber has never seen you in person, that date applies to you. Ask before December, not after.

Solcara Health sees patients at 496 Bramson Ct in Mount Pleasant and at The Longevity Club, 163 Rutledge Ave in downtown Charleston. Learn about testosterone therapy, bioidentical hormone therapy, what happens at a first TRT visit and the areas Solcara serves, or call 843-981-0870.

References

  1. [1] SC Department of Public Health. South Carolina Prescription Monitoring Program 2024 Annual Report (Schedule III trends). May 2025 (posted June 2025). https://dph.sc.gov/sites/scdph/files/2025-06/2024_SC_PMP_Annual_Report.pdf
  2. [2] US Census Bureau via FRED. Resident Population in Charleston-North Charleston, SC (MSA) (CRLPOP). March 2026. https://fred.stlouisfed.org/series/CRLPOP
  3. [3] Code of Federal Regulations. 21 CFR 1306.25(a) and (e), annual edition revised as of April 1, 2025. April 2025. https://www.govinfo.gov/content/pkg/CFR-2025-title21-vol9/xml/CFR-2025-title21-vol9-sec1306-25.xml
  4. [4] Charleston Regional Development Alliance. Population and Demographics. Read November 9, 2026. https://crda.org/regional-data/population-demographics/
  5. [5] Code of Federal Regulations. 21 CFR 1308.13(f), Schedule III anabolic steroids, annual edition revised as of April 1, 2025. April 2025. https://www.govinfo.gov/content/pkg/CFR-2025-title21-vol9/xml/CFR-2025-title21-vol9-sec1308-13.xml
  6. [6] United States Code. 21 U.S.C. 802(41)(A), 2023 edition. https://www.govinfo.gov/content/pkg/USCODE-2023-title21/html/USCODE-2023-title21-chap13-subchapI-partA-sec802.htm
  7. [7] US Census Bureau. Vintage 2025 population estimates (press release). January 2026. https://www.census.gov/newsroom/press-releases/2026/population-growth-slows.html
  8. [8] Code of Federal Regulations. 21 CFR 1306.22(a), annual edition revised as of April 1, 2025. April 2025. https://www.govinfo.gov/content/pkg/CFR-2025-title21-vol9/xml/CFR-2025-title21-vol9-sec1306-22.xml
  9. [9] Code of Federal Regulations. 21 CFR 1306.25(a), shared database exception. April 2025. https://www.govinfo.gov/content/pkg/CFR-2025-title21-vol9/xml/CFR-2025-title21-vol9-sec1306-25.xml
  10. [10] Code of Federal Regulations. 21 CFR 1306.25(b)(1) to (b)(4). April 2025. https://www.govinfo.gov/content/pkg/CFR-2025-title21-vol9/xml/CFR-2025-title21-vol9-sec1306-25.xml
  11. [11] Drug Enforcement Administration. Transfer of Electronic Prescriptions for Schedules II-V Controlled Substances Between Pharmacies for Initial Filling, 88 FR 48365. July 2023. https://www.federalregister.gov/documents/2023/07/27/2023-15847/transfer-of-electronic-prescriptions-for-schedules-ii-v-controlled-substances-between-pharmacies-for
  12. [12] Drug Enforcement Administration. 88 FR 48365, regulatory analysis and discussion. July 2023. https://www.federalregister.gov/documents/2023/07/27/2023-15847/transfer-of-electronic-prescriptions-for-schedules-ii-v-controlled-substances-between-pharmacies-for
  13. [13] United States Code. 21 U.S.C. 829(e)(2)(A) (Ryan Haight Online Pharmacy Consumer Protection Act of 2008), 2023 edition. https://www.govinfo.gov/content/pkg/USCODE-2023-title21/html/USCODE-2023-title21-chap13-subchapI-partC-sec829.htm
  14. [14] DEA Diversion Control Division. Registration FAQ (EO-DEA181, November 2, 2020; EO-DEA089, October 21, 2020). https://www.deadiversion.usdoj.gov/faq/registration-faq.html
  15. [15] Code of Federal Regulations. 21 CFR 1301.12(a), annual edition revised as of April 1, 2025. April 2025. https://www.govinfo.gov/content/pkg/CFR-2025-title21-vol9/xml/CFR-2025-title21-vol9-sec1301-12.xml
  16. [16] DEA and HHS. Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications, 90 FR 61301 (amending 21 CFR 1307.41). December 2025. https://www.federalregister.gov/documents/2025/12/31/2025-24123/fourth-temporary-extension-of-covid-19-telemedicine-flexibilities-for-prescription-of-controlled
  17. [17] DEA and HHS. 90 FR 61301, preamble (stakeholder summary of unpublished data). December 2025. https://www.federalregister.gov/documents/2025/12/31/2025-24123/fourth-temporary-extension-of-covid-19-telemedicine-flexibilities-for-prescription-of-controlled
  18. [18] Drug Enforcement Administration. Special Registrations for Telemedicine and Limited State Telemedicine Registrations (proposed rule), 90 FR 6541. January 2025. https://www.federalregister.gov/documents/2025/01/17/2025-01099/special-registrations-for-telemedicine-and-limited-state-telemedicine-registrations
  19. [19] SC Department of Public Health. South Carolina Prescription Monitoring Program 2024 Annual Report (prescriber location). May 2025 (posted June 2025). https://dph.sc.gov/sites/scdph/files/2025-06/2024_SC_PMP_Annual_Report.pdf
  20. [20] SC Department of Public Health. SC PMP 2024 Annual Report (introduction; timeline, December 2020 entry: interstate data sharing). May 2025 (posted June 2025). https://dph.sc.gov/sites/scdph/files/2025-06/2024_SC_PMP_Annual_Report.pdf
  21. [21] South Carolina Code of Laws. S.C. Code Ann. 44-53-1640 and 44-53-1645. Read November 9, 2026. https://www.scstatehouse.gov/code/t44c053.php
  22. [22] South Carolina Code of Laws. S.C. Code Ann. 44-53-360(k) (electronic prescribing of Schedule II to V controlled substances, with exemptions). Read November 9, 2026. https://www.scstatehouse.gov/code/t44c053.php
  23. [23] DEA Diversion Control Division. Registration FAQ (EO-DEA185, November 2, 2020). https://www.deadiversion.usdoj.gov/faq/registration-faq.html
  24. [24] DEA and HHS. 90 FR 61301, section I, Background (Ryan Haight Act in-person evaluation). December 2025. https://www.federalregister.gov/documents/2025/12/31/2025-24123/fourth-temporary-extension-of-covid-19-telemedicine-flexibilities-for-prescription-of-controlled
  25. [25] Federal Register. Documents search: Drug Enforcement Administration, term "telemedicine", published on or after January 1, 2026 (2 results, neither a telemedicine prescribing rule or extension). Read November 9, 2026. https://www.federalregister.gov/api/v1/documents.json?conditions%5Bagencies%5D%5B%5D=drug-enforcement-administration&conditions%5Bterm%5D=telemedicine&conditions%5Bpublication_date%5D%5Bgte%5D=2026-01-01
Ashley Harwyn, PA-C, smiling in front of a woven rattan chair.

About the author

Ashley Harwyn, PA-C, ABAAHP

Full bio

This article is for general education and is not medical advice. It does not create a provider-patient relationship. Talk with a licensed clinician about your own situation before starting, stopping or changing any treatment. Solcara Health, 496 Bramson Ct, Ste 120, Mount Pleasant, SC 29464 and 163 Rutledge Ave, Ste 202, Charleston, SC 29403. 843-981-0870.

Return to blog